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Abstract: Coronavirus disease 19 (COVID-19), caused by infection with the severe acute respiratory syn-
drome coronavirus 2 (Sars-CoV-2), has become a worldwide pandemic (1). Symptoms of COVID-19 vary
widely and range from asymptomatic disease to severe pneumonia and multiorgan failure (2). A severe
disease course is more likely in older patients and patients with pre-existing respiratory and cardiovascu-
lar conditions (2). Patients with severe Sars-CoV-2 infection may present with ischaemic stroke (3, 4) or
even fatal intracerebral haemorrhage (5). To date, little is known about the neuropathological sequelae
of COVID-19. The largest published autopsy series of COVID-19 neuropathology reported microthrombi
and acute haemorrhagic infarction in a significant number of patients (6), while another more recent study
found evidence of lymphocytic encephalitis and meningitis (7). Endotheliitis of the brain and extraneural
organs has been shown in Sars-CoV infected patients (8). Similarly, it is a recurrent feature in the lungs
and other peripheral organs of Sars-CoV-2 infected patients (9) but has not yet been reported in the
central nervous system. We speculated that cerebrovascular pathology in COVID-19 patients could be a
direct consequence of hitherto unidentified cerebral endotheliitis caused by Sars-CoV-2.
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Main text
Coronavirus disease 19 (COVID-19), caused by infection with the severe acute 
respiratory syndrome coronavirus 2 (Sars-CoV-2), has become a worldwide pandemic 
(1). Symptoms of COVID-19 vary widely and range from asymptomatic disease to severe 
pneumonia and multiorgan failure (2). A severe disease course is more likely in older 
patients and patients with pre-existing respiratory and cardiovascular conditions (2). 
Patients with severe Sars-CoV-2 infection may present with ischaemic stroke (3, 4) or 
even fatal intracerebral haemorrhage (5). To date, little is known about the 
neuropathological sequelae of COVID-19. The largest published autopsy series of 
COVID-19 neuropathology reported microthrombi and acute haemorrhagic infarction in a 
significant number of patients (6), while another more recent study found evidence of 
lymphocytic encephalitis and meningitis (7). Endotheliitis of the brain and extraneural 
organs has been shown in Sars-CoV infected patients (8). Similarly, it is a recurrent 
feature in the lungs and other peripheral organs of Sars-CoV-2 infected patients (9) but 
has not yet been reported in the central nervous system. We speculated that 
cerebrovascular pathology in COVID-19 patients could be a direct consequence of 
hitherto unidentified cerebral endotheliitis caused by Sars-CoV-2. 
We retrospectively analysed all brain autopsies from Sars-CoV-2 infected patients 
referred to our department, for the presence of vasculopathic changes and cerebral 
haemorrhage (Supplementary Table 1). We excluded two patients with overt 
disseminated intravascular coagulopathy (10) (DIC, one patient was described previously 
(11)). Accordingly, we present a detailed neuropathological work-up of four Sars-CoV-2 
infected patients.
Detailed clinical information is provided in Supplementary Table 1 and the Supplementary 
data. Four patients (3 males, 1 female, age range 70 - 81 years) presented with 
progressive respiratory symptoms, 3 were diagnosed with bilateral COVID-19 pneumonia 
during hospitalisation. Patient 2 also presented with bilateral pneumonia, consistent with 
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although two previous nasopharyngeal swabs were negative. None of the patients 
showed laboratory signs of overt DIC (Supplementary Table 1) (10). Ante-mortem cranial 
tomography studies performed in patient 1 were unremarkable. All patients died 5-15 
days after admission.
Endotheliitis in the lungs of patient 1 (9) and inflammatory olfactory neuropathy in 
patients 1 and 3 have been described earlier (12). Gross examination of the brains was 
unremarkable except in two cases (patients 1 and 4), which revealed diffuse petechial 
haemorrhage, most prominent at the grey-white matter junction of the neocortex (Figure 
1a, Supplementary Table 1). Corresponding post-mortem magnetic resonance imaging 
(MRI) of one brain showed multiple cerebral petechial haemorrhages on susceptibility 
weighted imaging (SWI) (patient 1, Figure 1b). On histology, the vast majority of the 
haemorrhages were fresh (Figure 1c), without evidence of haemoglobin breakdown 
products on Prussian blue stains. Juxtacortical microbleeds were observed in all patients, 
most conspicuous in the frontal lobe. Additionally, petechial haemorrhages were 
observed in the thalamus, mesencephalon and pons (Supplementary Table 1). In one 
case, multiple intraparenchymal subacute haemorrhages were found in the corpus 
callosum (patient 4, Figure 1d). Fresh haemorrhages were both perivascular, as well as 
intraparenchymal without relation to vasculature. In all cases, there was evidence of 
diffuse intravascular thrombosis. In small veins of the basal ganglia of two patients (1 and 
3), intra-endothelial lymphocytic and monocytic inflammation with occasional apoptotic 
figures were observed, consistent with the previously reported “endotheliitis” in Sars-
CoV-2 infected patients (9) (patients 1 and 3, Figure 1e). Immunohistochemistry for 
ACE2 consistently revealed detectable expression in all bar one patient diagnosed with 
COVID-19 (Supplementary Figure 1). Additional staining of three pre-pandemic autopsy 
controls revealed very faint or absent ACE2 expression (Supplementary Figure 1 and 
Supplementary Data). To test whether the younger age of the controls confounded ACE2 
expression, we compared ACE2 transcripts from basal ganglia from the Genotype-Tissue 
Expression project (GTEx, total of n = 205 patients). We did not see increased gene 
expression during aging (Supplementary Data). Additional lymphocytic “cuffing” was 
observable in two cases (patients 1 and 3). Congo red stains and immunohistochemistry 
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Cerebral petechial haemorrhages may represent a histological correlate of the 
neurological symptoms observed in the COVID-19 patients described in this case series. 
Endothelial cell infection is a recurrent feature in the lungs and other peripheral organs of 
COVID-19 patients (9) but has not yet been reported in the brain (6, 7). We report here 
for the first time the presence of intracerebral endotheliitis in two patients diagnosed with 
Sars-CoV-2 infection. The observed endotheliitis could be an autoimmune, late-onset 
phenomenon or a direct effect of endothelial infection as angiotensin-converting enzyme 
2 (ACE2), the Sars-CoV-2 receptor, is expressed in the brain vasculature 
(Supplementary Figure 1 and (13)). Here, we found higher ACE2 expression in the brain 
vasculature of patients with endotheliitis than in COVID-19 patients without endotheliitis 
or than in control patients (Supplementary Figure 1). Although control patients were 
younger on average, comparison of publicly available gene expression data did not show 
increased ACE2 expression in the basal ganglia during aging (Supplementary Data). The 
small number of patients analysed, however, precludes a causal inference. 
Recently, the concept of critical illness-associated microbleeds (CRAM) was introduced 
(14). The topology of the microbleeds described in this condition is somewhat similar, but 
not identical, to the patients in our cohort as well as in hypoxaemic patients after high-
altitude exposure (14). Correspondingly, hypoxia was the cause of death in all patients 
from the present case series. The nosological distinction between microbleeds in critically 
ill patients and COVID-19 patients is not entirely clear. CRAM show some predilection for 
the corpus callosum, while in our case series, this pattern was only observed in one 
patient. Similarly, 3 out of 4 patients in our series showed a marked involvement of the 
brainstem, in contrast to 4 out of 25 patients described by Fanou et al. (14) Still, 
haemorrhages might have been aggravated by concomitant acute respiratory distress 
syndrome.
All patients suffered from arterial hypertension and hypertensive microangiopathy, 
however, hypertensive microbleeds favour the deep grey matter and the infratentorial 
region (15). Elevated risk for thrombosis and pulmonary embolism is well-document in 
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antiplatelet therapy, which may have predisposed them to haemorrhagic events. 
Hydroxychloroquine, which was administered to three patients, has also been reported to 
cause bleeding (16). On autopsy, no haemorrhage was seen at predilection sites such as 
the gastrointestinal tract, thus making solely drug-induced haemorrhage unlikely. (16) 
In both patients suffering from prolonged coma and negative wake-up attempts, 
intraparenchymal haemorrhages had already been observed grossly suggesting a 
positive correlation between the severity of the vasculopathy and acute sleep-wake 
dysregulation. Accordingly, the distribution of microbleeds showed a neuroanatomical 
preference for central modulators of wakefulness (pons, mesencephalon and paramedian 
thalamus, Figure 1e). A similar distribution of brainstem lesions leading to disturbed 
sleep-wake regulation can be observed in neurodegenerative diseases, traumatic brain 
injury and acute vascular events (17). A major drawback of our study is the plethora of 
co-morbidities, such as acute respiratory distress syndrome, hypertension and 
prophylactic anticoagulation, all of which increase the risk of intracerebral haemorrhage. 
It seems likely that we investigated an at-risk cohort, which may explain the unusually 
high occurrence of intracerebral bleeding in our case series compared to another recently 
published study (18). Although it is tempting to deduce a causal connection between 
intracerebral haemorrhage, Sars-CoV-2 induced endothelial inflammation and 
hypoxaemic damage, the retrospective nature of this study and the small number of 
patients allows for limited conclusions and necessitates further studies. 
Neurological symptoms associated with COVID-19 have been described with manifold 
aetiologies, such as ischaemic stroke, haemorrhagic encephalopathy and others (19). In 
contrast to a recently published case report, we did not observe signs of perivascular 
demyelination (20). Cerebral microbleeds have been associated with increased risk for 
cardiovascular mortality (21) and cognitive deterioration (22). Additionally, emerging 
evidence suggests rapidly waning humoral anti-Sars-CoV-2 immunity might be 
associated with a risk of recurrent infection and subsequent cognitive dysfunction (23). 
The temporal evolution of COVID-19-associated cerebrovascular pathology remains 
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Figure legend
Figure 1. (A) Gross examination was significant for multiple, mostly juxtacortical 
haemorrhages (patient 1). (B) Post-mortem susceptibility weighted imaging (SWI) of brain 
revealed multiple microbleeds/haemorrhages (patient 1). (C) H&E-stained section 
showing fresh haemorrhages in the centrum semiovale (patient 2). (D) Subacute 
haemorrhage containing macrophages (CD68, right insert) and blood breakdown 
products (Prussian blue, Fe, left insert) in the corpus callosum of patient 4. (E) Diffuse 
intravascular microthrombosis and endotheliitis in the basal ganglia of patient 1. Elevated 
apoptosis, as demonstrated by cleaved caspase 3 immunohistochemistry, was 
observable in endothelial cells and intramural infiltrates but not in the adjacent 
parenchyma (cleaved casp. 3, left insert). Intra-endothelial lymphocytes stained positive 
on CD45 immunohistochemistry (CD45, right insert). (F) Schematic localisation of the 
intracerebral haemorrhages: 1) frontal cortex 2) other isocortical areas, as well as deep 
grey matter 3) mesencephalon 4) pons 5) medulla oblongata.
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Table 1: Clinical and pathological characteristics of the patients  
Variable Patient 1 Patient 2 Patient 3 Patient 4 
Age, y 70 77 79 81 
Gender Male Female Male Male 
Pre-existing disease; 
Cardiovascular risk factors 
Hypertension, coronary artery 
disease, atrial fibrillation, kidney 
transplantation 2013 
Hypertension, depression 
Obesity, paroxysmal atrial 
fibrillation, severe pulmonary 
hypertension, chronic renal 
failure, M. Waldenström 
Hypertension, coronary artery 











ASA, Losartan, Metolprolol, 








No intubation / 53% measured 2 
days before death 
No intubation / 70% 89% 
Anticoagulation in the last 3 
days before CNS disorder 
ASA at admission, therapeutic 
anticoagulation with 
unfractionated heparin in ICU 
Prophylactic Enoxaparine 40 
mg/d 
Apixaban 
Prophylactic dosage with 
unfractionated heparin 
CNS disorder 
Confusion at admission, 
asymmetric reactive pupils, 
negative wake-up 
No CNS disorder No CNS disorder Negative wake-up 
Concomitant condition* Invasive mechanical ventilation, O2-Therapy via high flow O2-Therapy Invasive mechanical ventilation, 
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prone positioning 
CRRT, mesenteric ischaemia, 
myocardial injury 
mask/nasal cannula pneumothorax 
Relevant pathological 
laboratory values at time of 
CNS disorder 
CRP 299 mg/l, lymphocyte 
count 0,29 G/l, IL-6 3919 ng/l, 
fibrinogen 6,7 g/l, d-dimer 2.42 
mg/l, thrombocyte count 177 G/l 
CRP 145 mg/l, lymphocyte 
count 0.78 G/l, thrombocyte 
count 427 G/l, fibrinogen 8.79 g/l 
CRP 246 mg/l, lymphocyte 
count 0,52 G/l, IL-6 NA , 
fibrinogen NA, d-dimer NA, 
thrombocyte count 238 G/l 
CRP 227 mg/l, lymphocyte 
count 0,82 G/l, IL-6 175 ng/l, 
fibrinogen 5,9 g/l, d-dimer 11,1 
mg/l 
DIC score ** 3 NA NA 3 
Time from disease onset to 
manifestations of CNS 
disorder, days 
2 No CNS disorder No CNS disorder 14 
Neuroimaging 
CT Scan: unremarkable 
Post-mortem brain MRI / SWI-
sequence: Multiple 
microbleeds/haemorrhages 
NA NA NA 
Outcome at ICU discharge 
Died from multi-organ failure 
and mesenterial ischaemia 
Died under palliative care 
 Died from hypoxaemia and 
severe pulmonary hypertension 
under palliative care 
Died from cardio-pulmonary 
failure under palliative care 
Pathological findings 
Brain weight, g 1374 1239 1364 1626 
Gross pathology 
Diffuse oedema; punctuate 
haemorrhage (frontal and 
parietal cortex, basal ganglia, 
pons, corpus callosum) 
unremarkable unremarkable 
Mild, patchy atherosclerosis; 
mild diffuse atrophy; 
punctuate haemorrhage (corpus 
callosum, hypothalamus, frontal 
and temporal cortex) 
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Haemorrhages     
Neocortex + + + +*** 
Hippocampus - + - - 
Basal ganglia - + + - 
Thalamus / Hypothalamus - + + + 
Stria olfactoria + + - - 
Mesencephalon + + + - 
Pons + + + - 
Medulla oblongata + + - - 
Cerebellum - + - - 
Other microscopic findings 
Endotheliitis, diffuse 
intravascular thrombosis, 
perivasal lymphocytic infiltrates, 
hypertensive microangiopathic 





Endotheliitis, a neuron with 
granulovacuolar degeneration in 





changes, subacute ischaemia 
frontal cortex 
Cerebral amyloid angiopathy 
(Congo red / beta amyloid) 
- - - - 
ASA acetylsalicylic acid, CNS central nervous system, CRP C-reactive protein, CRRT continuous renal replacement therapy, CT computed 
tomography, DIC disseminated intravascular coagulopathy, ICU intensive care unit, IL-6 Interleukine 6, MRI magnetic resonance imaging, NA 
not available, SpO2 peripheral oxygen saturation, SWI Susceptibility weighted imaging,  
* Concomitant condition: additional findings which occurred at the time of the neurological deficits  
** DIC score according to International Society on Thrombosis and Haemostasis 11 
*** this patient harboured fresh juxtacortical haemorrhages and multiple subacute haemorrhages in the corpus callosum 
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